01. Yu-Hung Chen, Li Min Yong, Yi-Feng Wu, Shu-Hsin Liu, Kun-Han Lue*. Influence of Feature Aggregation and Selection Methods on ¹⁸F-FDG PET Radiomics for Survival Prediction in Patients with Lymphoma. Nucl Med Commun. 2026;47:462-469 (SCIE).
02. Kun-Han Lue, Yu-Hung Chen, Sung-Chao Chu, Chih-Bin Lin, Bee-Song Chang, Pau-Yuan Chang, Shu-Hsin Liu. Combining the prognostic values of entropy-based heterogeneity features from ¹⁸F-fluorodeoxyglucose PET and transmission computed tomography using machine learning in patients with lung adenocarcinoma undergoing curative surgery. Nucl Med Commun. 2026;47:479-489 (SCIE).
03. Kun-Han Lue, Yung-Hsuan Wang, Yu-Hung Chen, Sung-Chao Chu, Chih-Bin Lin, Shu-Hsin Liu. The prognostic value of ¹⁸F-FDG PET-derived whole-body feature in patients with lung adenocarcinoma treated with EGFR-targeted therapy. Ann Nucl Med. 2026;40:121-135 (SCIE).
04. Kun-Han Lue, Yu-Hung Chen, Sung-Chao Chu, Chih-Bin Lin, Tso-Fu Wang, Shu-Hsin Liu. Prognostic value of combining clinical factors, ¹⁸F-FDG PET-based intensity, volumetric features, and deep learning predictor in patients with EGFR-mutated lung adenocarcinoma undergoing targeted therapies: a cross-scanner and temporal validation study. Ann Nucl Med. 2024;38:647-658 (SCIE).
05. Yu-Hunga Chen, Kun-Han Lue, Sung-Chao Chu, Chih-Bine Lin, Shu-Hsin Liu. The value of ¹⁸F-fluorodeoxyglucose positron emission tomography-based radiomics in non-small cell lung cancer. Tzu Chi Med J. 2024 Sep 3;37(1):17-27 (ESCI).
06. Yu-Hung Chen, Kuo-Yi Kan, Shu-Hsin Liu, Hsin-Hon Lin, Kun-Han Lue*. Impact of respiratory motion on ¹⁸F-FDG PET radiomics stability: Clinical evaluation with a digital PET scanner. J Appl Clin Med Phys. 2023;24:e14200 (SCIE).
07. Kun-Han Lue, Yu-Hung Chen, Sung-Chao Chu, Bee-Song Chang, Chih-Bin Lin, Yen-Chang Chen, Hsin-Hon Lin, Shu-Hsin Liu. A comparison of ¹⁸F-FDG PET-based radiomics and deep learning in predicting regional lymph node metastasis in patients with resectable lung adenocarcinoma: a cross-scanner and temporal validation study. Nucl Med Commun. 2023;44:1094-1105 (SCIE).
08. Kun-Han Lue*, Yu-Hung Chen, Yi-Feng Wu, Shu-Hsin Liu. Influence of the methodological aspects of the dichotomization of total metabolic tumor volume measured through baseline fluorine-18 fluorodeoxyglucose PET on survival prediction in lymphoma. Nucl Med Commun. 2023;44:74–80 (SCIE).
09. Bee-Song Chang, Tai-Chu Peng, Kun-Han Lue, Yi-Feng Wu, Chun-Hou Huang. Comprehensive assessment of the clinical risk factors of postoperative adverse events and survival in patients with non-small-cell lung cancer. In Vivo. 2023;37:1358-1364 (SCIE).
10. Yu-Hung Chen, Kun-Han Lue, Chih-Bin Lin, Kuang-Chi Chen, Sheng-Chieh Chan, Sung-Chao Chu, Bee-Song Chang, Yen-Chang Chen. Genomic and glycolytic entropy are reliable radiogenomic heterogeneity biomarkers for non-small cell lung cancer. Int J Mol Sci. 2023;24:3988 (SCIE).
11. Min-Feng Shih, Kun-Han Lue, Tso-Fu Wang, Sung-Chao Chu, Chun-Hou Huang. Association between the neutrophil-to-lymphocyte ratio and infection and survival in diffuse large B cell lymphoma. In Vivo. 2023;37:948-954 (SCIE).
12. Yu-Hung Chen, Kun-Han Lue, Sung-Chao Chu, Bee-Song Chang, Chih-Bin Lin. The combined tumor-nodal glycolytic entropy improves survival stratification in nonsmall cell lung cancer with locoregional disease. Nucl Med Commun. 2023;44:100–107 (SCIE).
13. Yu-Hung Chen, Yen-Chang Chen, Kun-Han Lue*, Sung-Chao Chu*, Bee-Song Chang, Ling-Yi Wang, Ming-Hsun Li, Chih-Bin Lin. Glucose metabolic heterogeneity correlates with pathological features and improves survival stratification of resectable lung adenocarcinoma. Ann Nucl Med. 2023;37:139-150 (SCIE).
14. Kun-Han Lue, Chun-Hou Huang, Tsung-Cheng Hsieh, Shu-Hsin Liu, Yi-Feng Wu, Yu-Hung Chen. Systemic inflammation index and tumor glycolytic heterogeneity help risk stratify patients with advanced EGFR-mutated lung adenocarcinoma treated with tyrosine kinase inhibitor therapy. Cancers. 2022;14:309 (SCIE).
15. Kun-Han Lue, Sung-Chao Chu, Ling-Yi Wang, Yen-Chang Chen, Ming-Hsun Li, Bee-Song Chang, Sheng-Chieh Chan, Yu-Hung Chen, Chih-Bin Lin, Shu-Hsin Liu. Tumor glycolytic heterogeneity improves detection of regional nodal metastasis in patients with lung adenocarcinoma. Ann Nucl Med. 2022;36:256-266 (SCIE).
16. Chun-Hou Huang, Kun-Han Lue, Peir-Rorg Chen, Tsung-Cheng Hsieh, Yu-Fu Chou. Association between sarcopenia and immediate complications and mortality in patients with oral cavity squamous cell carcinoma undergoing surgery. Cancers. 2022;14:785 (SCIE).
17. Chun-Hou Huang, Peir-Rorg Chen, Kun-Han Lue, Tsung-Cheng Hsieh, Yu-Fu Chou. Evaluation of sarcopenia, frailty, and inflammation on adverse events and survival outcomes in patients with oral cavity squamous cell carcinoma under adjuvant chemoradiotherapy. J Pers Med. 2021;11:936 (SCIE).
18. Yu-Hung Chen, Sung-Chao Chu, Ling-Yi Wang, Tso-Fu Wang, Kun-Han Lue, Chih-Bin Lin, Bee-Song Chang, Dai-Wei Liu, Shu-Hsin Liu, Sheng-Chieh Chan. Prognostic value of combining primary tumor and nodal glycolytic–volumetric parameters of ¹⁸F-FDG PET in patients with non-small cell lung cancer and regional lymph node metastasis. Diagnostics. 2021;11:1065 (SCIE).
19. Kun-Han Lue, Yi-Feng Wu, Hsin-Hon Lin, Tsung-Cheng Hsieh, Shu-Hsin Liu, Sheng-Chieh Chan, Yu-Hung Chen. Prognostic value of baseline radiomic features of ¹⁸F-FDG PET in patients with diffuse large B-cell lymphoma. Diagnostics. 2021;11:36 (SCIE).
20. Yu-Hung Chen, Tso-Fu Wang, Sung-Chao Chu, Chih-Bin Lin, Ling-Yi Wang, Kun-Han Lue, Shu-Hsin Liu, Sheng-Chieh Chan. Incorporating radiomic features of pretreatment ¹⁸F-FDG PET improves survival stratification in patients with EGFR-mutated lung adenocarcinoma. PLoS ONE. 2020;15:e0244502 (SCIE).
21. Yu-Hung Chen, Hwa-Tsung Chen, Ming-Che Lee, Shu-Hsin Liu, Ling-Yi Wang, Kun-Han Lue, Sheng-Chieh Chan. Preoperative ¹⁸F-fluorocholine PET/CT for detection of hyperfunctioning parathyroid glands in secondary or tertiary hyperparathyroidism. Ann Nucl Med. 2020;34:527-537 (SCIE).
22. Kun-Han Lue, Yi-Feng Wu, Shu-Hsin Liu, Tsung-Cheng Hsieh, Keh-Shih Chuang, Hsin-Hon Lin, Yu-Hung Chen. Intratumour heterogeneity assessed by ¹⁸F-FDG PET predicts treatment response and survival outcomes in Hodgkin lymphoma. Acad Radiol. 2020;27:e183-e192 (SCIE).
23. Chun-Hou Huang, Kun-Han Lue, Tsung-Cheng Hsieh, Shu-Hsin Liu, Tso-Fu Wang, Tai-Chu Peng. Association between sarcopenia and clinical outcomes in patients with esophageal cancer under neoadjuvant therapy. Anticancer Res. 2020;40:1175-1181 (SCIE).
24. Kun-Han Lue, Yi-Feng Wu, Shu-Hsin Liu, Tsung-Cheng Hsieh, Keh-Shih Chuang, Hsin-Hon Lin, Yu-Hung Chen. Prognostic value of pretreatment radiomic features of ¹⁸F-FDG PET in Hodgkin lymphoma. Clin Nucl Med. 2019;44:e559-e565 (SCIE).
25. Yu-Hung Chen, Kun-Han Lue, Sung-Chao Chu, Bee-Song Chang, Ling-Yi Wang, Dai-Wei Liu, Shu-Hsin Liu, Yin-Kai Chao, Sheng-Chieh Chan. Combining radiomic features and traditional ¹⁸F-FDG PET parameters with clinical profiles to improve prognostic stratification in esophageal squamous cell carcinoma. Ann Nucl Med. 2019;33:657-670 (SCIE).
26. Yu-Hung Chen, Ching-Jung Chen, Ling-Yi Wang, Kun-Han Lue, Ching-Lin Sung, Shu-Hsin Liu. Comparison of attenuation correction methods for semiquantitative parameters of TRODAT-1 SPECT. Ann Nucl Med Mol Imaging. 2019;32:63-67.
27. Hung-Jen Hsieh, Kun-Han Lue, Hsin-Chi Tsai, Chau-Chin Lee, Shin-Yuan Chen, Pan-Fu Kao. ¹⁸F-FDOPA PET demonstrates dopaminergic system abnormalities in obsessive–compulsive disorder. Psychiatry Clin Neurosci. 2014;68:292-298 (SCIE).
28. Kun-Han Lue, Hsin-Hon Lin, Chih-Hao K. Kao, Hung-Jen Hsieh, Shu-Hsin Liu, Keh-Shih Chuang. A simple algorithm for subregional striatal uptake analysis with partial volume correction in dopaminergic PET imaging. Ann Nucl Med. 2014;28:33-41 (SCIE).
29. I-Cheng Chang, Kun-Han Lue, Hung-Jen Hsieh, Shu-Hsin Liu, Chih-Hao K. Kao. Automated striatal uptake analysis of ¹⁸F-FDOPA PET images in Parkinson disease. Ann Nucl Med. 2011;25:796-803 (SCIE).
30. Hung-Jen Hsieh, Kun-Han Lue, Chih-Hao K. Kao, Yung-Hsiang Hsu, Ming-Chien Liu, Pan-Fu Kao. Portosystemic collateral circulation demonstrated by Tc-99m-RBC SPECT/CT. Clin Nucl Med. 2009;34:958-959 (SCIE).
31. Hung-Jen Hsieh, Kun-Han Lue, Bee-Song Chang, Chih-Hao K. Kao, Shu-Hsin Liu, Pan-Fu Kao. Port-A catheter fracture identified on PET/CT. Ann Nucl Med Sci. 2009;22:47-51.
32. Hung-Jen Hsieh, Kun-Han Lue. Cephalad malposition of kidney as thoracic abnormality in Tc-99m MDP bone scintigraphy. Tzu Chi Med J. 2008;20:314-317 (ESCI).

 

01. Kun-Han Lue, Tien-Hsin Chang, Ching-Yuan Chen, Yu-Hung Chen, Hsin-Hon Lin. Coronary artery disease prediction by machine learning radiomics with SPECT MPI polar maps. Japan Society of Nuclear Medicine, 2025 Annual Scientific Meeting, Kyoto, Japan.
02. Yu-Hung Chen, Kun-Han Lue, Sheng-Chuan Huang, Yi-Feng Wu, Sung-Chao Chu, Shu-Hsin Liu. Value of whole-body ¹⁸F-FDG PET radiomics for predicting bone marrow involvement in patients with diffuse large B-cell lymphoma. Taiwan Society of Nuclear Medicine, 2025 Annual Meeting, Taipei, Taiwan.
03. Tan Sze Ian, Yu-Hung Chen, Kun-Han Lue, Shu-Hsin Liu. Assessing respiratory motion stability of novel ¹⁸F-FDG PET-derived morphological features. Taiwan Society of Nuclear Medicine, 2025 Annual Meeting, Taipei, Taiwan.
04. Kun-Han Lue, Yu-Hung Chen. AI Task Force radiomic challenge results and presentations: Best performing model for continuous outcomes. Society of Nuclear Medicine and Molecular Imaging (SNMMI), 2024 Annual Meeting, Toronto, Canada.
05. Yu-Hung Chen, Kun-Han Lue, Kuang-Chi Chen, Shu-Hsin Liu. Comparing machine-learning models with ¹⁸F-FDG PET-based radiomics in subtyping EGFR mutations of lung adenocarcinoma. Taiwan Society of Nuclear Medicine, 2024 Annual Meeting, Taipei, Taiwan.
06. Yu-Hung Chen, Kun-Han Lue, Kuang-Chi Chen, Shu-Hsin Liu. A machine-learning approach using ¹⁸F-FDG PET-based radiomics to predict regional lymph node metastasis in patients with resectable lung adenocarcinoma. Taiwan Society of Nuclear Medicine, 2024 Annual Meeting, Taipei, Taiwan.
07. Tan Sza Lan, Kun-Han Lue, Yu-Hung Chen, Shu-Hsin Liu. The effect of resampling on ¹⁸F-FDG PET-based radiomic features. Taiwan Society of Nuclear Medicine, 2024 Annual Meeting, Taipei, Taiwan.
08. Yu-Qun Chu, Ting-Chen Huang, Yu-Hung Chen, Kun-Han Lue, Yen-Chang Chen, Shu-Hsin Liu. Correlation of ¹⁸F-FDG PET, structural CT, and histopathological heterogeneity features and their prognostic values in lung adenocarcinoma. Taiwan Society of Nuclear Medicine, 2024 Annual Meeting, Taipei, Taiwan.
09. Ting-Chen Huang, Yu-Qun Chu, Yu-Hung Chen, Kun-Han Lue, Shu-Hsin Liu. Intestinal uptake of ^99mTc-diphosphonate and ¹⁸F-fluoride bone-seeking tracers: A report of three cases. Taiwan Society of Nuclear Medicine, 2024 Annual Meeting, Taipei, Taiwan.
10. Kun-Han Lue, Kuo-Yi Kan, Yu-Hung Chen, Shu-Hsin Liu, I-Ling Shih, Hsin-Hon Lin. Clinical evaluation of ¹⁸F-FDG PET radiomics stability to respiratory motion using a data-driven respiratory gating algorithm. European Association of Nuclear Medicine (EANM), 2023 Annual Congress, Vienna, Austria.
11. Kun-Han Lue, Yu-Hung Chen, Li Min Yong, Xin Yi Wong, Shu-Hsin Liu, Hsin-Hon Lin. Convolutional neural network for prediction of early disease progression in patients with advanced EGFR-mutated lung adenocarcinoma receiving tyrosine kinase inhibitor therapy based on ¹⁸F-FDG PET images. EANM, 2023 Annual Congress, Vienna, Austria.
12. Li Min Yong, Xin Yi Wong, Yu-Hung Chen, Shu-Hsin Liu, Hsin-Hon Lin, Kun-Han Lue. Effect of feature selection methods on prognostic analysis of ¹⁸F-FDG PET radiomics in lymphoma. EANM, 2023 Annual Congress, Vienna, Austria.
13. Xin Yi Wong, Li Min Yong, Yu-Hung Chen, Shu-Hsin Liu, Kun-Han Lue. Using different dichotomization methods for lesion dissemination to predict survival outcomes in lymphoma patients. EANM, 2023 Annual Congress, Vienna, Austria.
14. Yu-Hung Chen, Kun-Han Lue, Sung-Chao Chu, Kuang-Chi Chen, Shu-Hsin Liu. Deep learning model for categorizing tumor mutation burden in non-small cell lung cancer. Taiwan Society of Nuclear Medicine, 2023 Annual Meeting, Taichung, Taiwan.
15. Ho-Yan Rong, Yu-Hung Chen, Kun-Han Lue, Shu-Hsin Liu. Cross-scanner validation of the prognostic value of glycolytic entropy in lung cancer. Taiwan Society of Nuclear Medicine, 2023 Annual Meeting, Taichung, Taiwan.
16. Ho Tim Shek, Kun-Han Lue, Chao-Yueh Yu, Chih-Chieh Chiang, Tzu-Pei Su, Hsin-Hon Lin. Deep learning-based automatic segmentation for myocardial perfusion SPECT imaging using V-Net. International Symposium of Medical Imaging and Radiological Sciences, 2023, Kaohsiung, Taiwan.
17. Yu-Hung Chen, Kun-Han Lue. Evaluation of radiomic feature reliability in lower resolution images using reduced-matrix-size ¹⁸F-FDG PET. Taiwan Society of Nuclear Medicine, 2022 Annual Meeting, Taipei, Taiwan.
18. Yu-Hung Chen, Kuang-Chi Chen, Kun-Han Lue, Sung-Chao Chu. Correlation of ¹⁸F-FDG PET features with glucose metabolic signature gene mutations in non-small cell lung cancer. Taiwan Society of Nuclear Medicine, 2022 Annual Meeting, Taipei, Taiwan.
19. Chung-Ying Huang, Yu-Hung Chen, Kun-Han Lue, Yi-Feng Wu, Sung-Chao Chu. Prognostic models combining systemic inflammation markers and tumor glycolytic-volumetric product in NSCLC with regional lymph node metastasis. Taiwan Society of Nuclear Medicine, 2022 Annual Meeting, Taipei, Taiwan.
20. Chao-Yueh Yu, Kun-Han Lue, Ho-Ting Yang, Tzu-Pei Su, Hsin-Hon Lin. Attenuation correction for myocardial perfusion SPECT using a multi-stream 3D residual network. IEEE Nuclear Science Symposium and Medical Imaging Conference, 2021, Yokohama, Japan.
21. Yu-Hung Chen, Yen-Chang Chen, Ming-Hsun Li, Sung-Chao Chu, Kun-Han Lue. Correlation between ¹⁸F-FDG PET glycolytic features and pathological morphology in lung adenocarcinoma. Taiwan Society of Nuclear Medicine, 2021 Annual Meeting, Taichung, Taiwan.
22. Yu-Hung Chen, Sung-Chao Chu, Kun-Han Lue, Sheng-Chieh Chan, Shu-Hsin Liu. Prognostic value of ¹⁸F-FDG PET in advanced small cell lung cancer. Taiwan Society of Nuclear Medicine, 2021 Annual Meeting, Taichung, Taiwan.
23. Ching-Lin Sung, Sze Ian Tan, Shu-Hsin Liu, Sheng-Chieh Chan, Kun-Han Lue. Image quality evaluation of digital PET/CT using different scanning times and reconstruction methods. Taiwan Society of Nuclear Medicine, 2021 Annual Meeting, Taichung, Taiwan.
24. Yu-Hung Chen, Ming-Hsun Li, Sung-Chao Chu, Kun-Han Lue, Shu-Hsin Liu, Sheng-Chieh Chan. Tumor glycolytic heterogeneity from ¹⁸F-FDG PET and its association with PD-L1 expression in esophageal squamous cell carcinoma. Taiwan Society of Nuclear Medicine, 2020 Annual Meeting, Taipei, Taiwan.
25. Yu-Hung Chen, Kun-Han Lue, Shu-Hsin Liu, Sheng-Chieh Chan. Comparison of ¹⁸F-FDG PET radiomic features between different software platforms. Taiwan Society of Nuclear Medicine, 2020 Annual Meeting, Taipei, Taiwan.
26. Ching-Lin Sung, Yu-Hung Chen, Kun-Han Lue, Shu-Hsin Liu, Sung-Chao Chu, Ching-Chun Ho. Identifying predictors of Tc-99m bone radiopharmaceutical interference in DXA using LASSO and logistic regression. Taiwan Society of Nuclear Medicine, 2020 Annual Meeting, Taipei, Taiwan.
27. Kun-Han Lue, Yu-Hung Chen, Hsin-Hon Lin, Yi-Feng Wu, Shu-Hsin Liu, Sheng-Chieh Chan. Metabolic tumor volume dichotomization methods for survival prediction in Hodgkin lymphoma. Australian and New Zealand Society of Nuclear Medicine, 2020 Annual Meeting, Sydney, Australia.
28. Kun-Han Lue, Hsin-Hon Lin, Yu-Hung Chen, Shu-Hsin Liu, Keh-Shih Chuang. Relationship between PSA kinetics and radiomic features of ¹⁸F-fluorocholine PET in prostate cancer. SNMMI, 2019 Annual Meeting, Anaheim, USA.
29. Kun-Han Lue, Hsin-Hon Lin, Yu-Hung Chen, Shu-Hsin Liu, Keh-Shih Chuang. Embedding partial volume correction in atlas-based substriatal uptake analysis for dopaminergic PET imaging. SNMMI, 2019 Annual Meeting, Anaheim, USA.
30. Hsin-Hon Lin, Chih-Chieh Chiang, Kun-Han Lue, Yu-Ching Ni, Keh-Shih Chuang. Distortion correction in dual-head PET breast imaging using an add-on Compton camera. EANM, 2016 Annual Congress, Barcelona, Spain.
31. Kun-Han Lue, Hsin-Hon Lin, Chang-Shiun Lin, Chih-Chieh Chiang, Keh-Shih Chuang. Effects of random, scatter, attenuation, and partial volume corrections on dopaminergic PET quantification. EANM, 2016 Annual Congress, Barcelona, Spain.
32. Keh-Shih Chuang, Kun-Han Lue, Hsin-Hon Lin, Hsin-Chao Wang, Yu-Ching Ni, Meei-Ling Jan. Improved attenuation correction for SPECT using iterative filtered backprojection reconstruction. EANM, 2014 Annual Congress, Gothenburg, Sweden.
33. Keh-Shih Chuang, Chih-Hung Chien, Hsin-Hon Lin, Kun-Han Lue, Chih-Chieh Chiang, Meei-Ling Jan. Dual-isotope simultaneous acquisition of Tc-99m and F-18 using PET with a beam stopper device. EANM, 2014 Annual Congress, Gothenburg, Sweden.
34. Hsin-Chau Wang, Kun-Han Lue, Hsin-Hon Lin, Keh-Shih Chuang. Improvement of attenuation correction for SPECT. International Symposium of Medical Imaging and Radiological Sciences, 2014, Taichung, Taiwan.
35. Shih-Chi Lin, Yi-Fang Wang, Kun-Han Lue, Hsin-Hon Lin, Keh-Shih Chuang. Improved scatter correction technique in PET imaging. AAPM, 2014 Annual Meeting, Austin, USA.
36. Yi-Fang Wang, Shih-Chi Lin, Chia-Hung Lu, Kun-Han Lue, Lu-Han Lai, Keh-Shih Chuang. Application of SIFT technique to microcalcification detection. AAPM, 2014 Annual Meeting, Austin, USA.
37. Kun-Han Lue, Hsin-Hon Lin, Chih-Hao K. Kao, Hung-Jen Hsieh, Shu-Hsin Liu, Keh-Shih Chuang. Partial volume correction for subregional striatal analysis in dopaminergic PET imaging. EANM, 2013 Annual Congress, Lyon, France.
38. Hsin-Hon Lin, Keh-Shih Chuang, Chih-Hung Chien, Kun-Han Lue, Chih-Chieh Chiang, Meei-Ling Jan. Simultaneous SPECT and PET dual-tracer imaging using a beam stopper device. EANM, 2013 Annual Congress, Lyon, France.
39. Kun-Han Lue, I-Cheng Chang, Hung-Jen Hsieh, Shu-Hsin Liu, Chih-Hao K. Kao. Objective manual striatal uptake analysis for ¹⁸F-FDOPA PET in Parkinson disease. Taiwan International Symposium on Radiopharmaceutical Development and Application, 2010, Hualien, Taiwan.
40. Hung-Jen Hsieh, Shin-Chi Tsai, Shin-Yuan Chen, Kun-Han Lue, Chih-Hao K. Kao. Neuronal circuitry and neuromodulatory mechanisms of deep brain stimulation in obsessive–compulsive disorder explored by ¹⁸F-FDG PET. Society of Nuclear Medicine, 2010 Annual Meeting, Utah, USA.